Eli Lilly Provides In-Line 2010 Forecast, Doesn’t Address “Patent Cliff” (LLY)
December 10th, 2009

Drug maker Eli Lilly & Co. (LLY) on Thursday delivered a 2010 earnings forecast that was in-line with analyst expectations, but gave no indication as to how earnings would be affected in the 2011-2014 period, when several of its patents expire.
Dividend.com archives (articles more than 30 days old) are only available to Dividend.com Premium subscribers.
Sign up for a Dividend.com Premium account for instant access to article archives, stock ratings on over 2,000 dividend-paying stocks, and much more! FREE TRIAL available!




RSS



Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the